Celiac Disease (CD), also known as coeliac disease/non-tropical sprue or gluten-sensitive enteropathy, is defined as a chronic, multiple-organ small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed people. It is a severe autoimmune disorder where the ingestion of gluten leads to damage in the small intestine; it is not an allergy caused by gluten.
&nbsp;
Celiac Disease Epidemiological Segmentation&nbsp;
<ul>
<li>The Epidemiological Segmentation of Celiac Disease in 7MM from 2017 to 2030 is segmented as:-&nbsp;</li>
<li>Total Prevalent Population of Celiac Disease</li>
<li>Total Diagnosed Prevalent Population of Celiac Disease</li>
<li>Gender-specific Diagnosed Prevalent Population of Celiac Disease</li>
<li>Type-specific Diagnosed Prevalent Population of Celiac Disease</li>
<li>Age-specific distribution of Celiac Disease</li>
</ul>
&nbsp;
Celiac Disease Epidemiology&nbsp;
<ul>
<li>The total prevalent population of Celiac Disease in 7 MM was 6,334,993 in 2017.&nbsp;</li>
</ul>
&nbsp;
<ul>
<li>In the United States, Celiac Disease cases were found to be 238,048 in Males, whereas 423,196 cases were found for Females in 2017.&nbsp;&nbsp;</li>
</ul>
&nbsp;
<a style="color: #0066cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/celiac-disease-cd-market" target="_blank" rel="noopener noreferrer">Celiac Disease Market</a>
The market size of Celiac Disease in 7MM was USD 1,242.8 Million in 2017.
&nbsp;
Celiac Disease Market Drivers
<ul>
<li>Robust Pipeline Activity</li>
<li>Increase in Awareness</li>
<li>Increasing Prevalence and Diagnosed Prevalence in Europe</li>
</ul>
&nbsp;
Celiac Disease Market Barriers
<ul>
<li>Economic Burden on Patients</li>
<li>Lack of Efficient Diagnosis</li>
<li>Differential Diagnosis</li>
</ul>
&nbsp;
Celiac Disease Emerging Drugs
The emerging drugs of the Celiac Disease market are&nbsp;
<ul>
<li>Larazotide Acetate (INN-202/AT-1001)</li>
<li>Latiglutenase (IMGX003/ALV003)</li>
<li>PRV-015</li>
<li>TAK-101</li>
<li>AG017</li>
<li>ZED1227</li>
</ul>
And many others.&nbsp;&nbsp;
&nbsp;
Celiac Disease Key Players
The key players in the Celiac Disease market are
<ul>
<li>9 Meters Biopharma</li>
<li>ImmunogenX</li>
<li>Provention Bio</li>
<li>Takeda/Cour Pharmaceuticals</li>
<li>Precigen ActoBio</li>
<li>Falk Pharma and Zedira</li>
</ul>
And many others.&nbsp;

Celiac Disease Market 

Celiac Disease Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.